The Patients’ Experience on Neuroimaging of Gliomas: A Cross-Sectional Survey Study

Glioma patient experience of MRI scans, repeated follow-up, and gadolinium-based contrast agents (GBCA) are unknown, despite the vulnerability of this patient group and relevant implications for clinics and science. This cross-sectional survey questioned 100 patients with primary brain tumors and found generally positive experiences with neuro-oncological scans. Age, diagnosis, and number of previous scans had little impact on the patient experience. However, women found MRI and intravenous injection significantly more uncomfortable. Also, patients would prefer GBCA-free MRIs if diagnostically equivalent. Patient knowledge towards GBCAs was limited and better information regarding GBCA and the MRI itself is needed.